FDA Warns of 48 Illnesses, One Death Linked to Diamond Shruumz Edibles
Medically reviewed by Drugs.com.
By Robin Foster HealthDay Reporter
WEDNESDAY, July 3, 2024 -- The U.S. Food and Drug Administration said Tuesday it is now investigating nearly 50 illnesses and one death that may be linked to eating Diamond Shruumz edibles.
Of the 48 people in 24 states who said they got sick after eating the chocolate bars, cones and gummies, one patient has died and 27 have been hospitalized, the FDA noted in an updated health alert.
Those who fell ill reported seizures, agitation, abnormal heart rates and loss of consciousness. The latest illness was reported Monday, FDA officials said.
Last week, the company that makes the edibles issued a full recall of all its edibles after discovering high levels of a mushroom toxin in the products.
The recall was issued "because such products contain muscimol, a chemical found in mushrooms of the genus amanita," California-based Prophet Premium Blends stated in its announcement.
"Muscimol could be a potential cause of symptoms consistent with those observed in persons who became ill after eating Diamond Shruumz products," the company added. Reported symptoms include seizures, agitation, involuntary muscle contractions, loss of consciousness, confusion, sleepiness, nausea and vomiting, abnormal heart rates and high/low blood pressure.
States with cases include Alabama, Arizona, California, Colorado, Georgia, Indiana, Iowa, Kentucky, Maryland, Minnesota, Missouri, Montana, Nevada, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina and Tennessee.
The FDA first advised consumers not to eat Diamond Shruumz microdosing chocolate bars two weeks ago, warning that people in four states had fallen ill. Some had to be intubated.
The recalled products were distributed nationwide through retail stores and mail order.
Back in late May, Prophet Premium received the first two complaints of people becoming ill after eating an entire chocolate bar. That prompted the company to conduct an analysis of its ingredients, which "showed higher than normal amounts of muscimol," the recall notice said.
The company said it has stopped producing and distributing the Diamond Shruumz product line while it and the FDA continue to investigate the cause of the illnesses.
Consumers who bought Diamond Shruumz products should stop using them and contact the company at 209-314-0881 or by email at [email protected] with their order number to get a refund.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-03 21:15
Read more
- American College of Gastroenterology, Oct. 25-30
- Dementia Death Rates in U.S. Older Adults Fluctuated From 2018 to 2022
- Global Coverage With Measles Vaccine Declined During COVID-19
- Sleep Apnea Increases Risk for Dementia in Older Adults Over Time
- Adverse Events Occur in More Than One-Third of Patients Admitted for Surgery
- No Long-Term Cognitive Effects Seen for Menopausal Hormone Therapy
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions